Flora Growth Corp. financial data

Symbol
FLGC on Nasdaq
Industry
Pharmaceutical Preparations
Location
3230 W. Commercial Boulevard, Suite 180, Fort Lauderdale, FL
State of incorporation
Ontario, Canada
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 115 % -26.6%
Quick Ratio 43.2 % -24.1%
Debt-to-equity 92.6 %
Return On Equity -346 % -93.3%
Return On Assets -74.2 % +31.6%
Operating Margin -26.7 % +68.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 13.4M shares +62.8%
Common Stock, Shares, Outstanding 13.4M shares +62.7%
Entity Public Float 13.7M USD +31136264%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 13.4K shares +92.4%
Weighted Average Number of Shares Outstanding, Diluted 13.4K shares +74.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 64.2M USD -5.52%
Research and Development Expense 252K USD +908%
General and Administrative Expense 1.71M USD +0.94%
Operating Income (Loss) -17.1M USD +69.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -17.4M USD +66.2%
Income Tax Expense (Benefit) -451K USD +83%
Net Income (Loss) Attributable to Parent -19.9M USD +66.7%
Earnings Per Share, Basic -1.64 USD/shares -256%
Earnings Per Share, Diluted -1.62 USD/shares -275%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.21M USD -11.6%
Accounts Receivable, after Allowance for Credit Loss, Current 3.92M USD +10.7%
Inventory, Net 7.86M USD -26.1%
Assets, Current 21.3M USD -10.8%
Property, Plant and Equipment, Net 518K USD -42.4%
Operating Lease, Right-of-Use Asset 1.45M USD +54.7%
Intangible Assets, Net (Excluding Goodwill) 3.78M USD -30.3%
Goodwill 2.15M USD
Other Assets, Noncurrent 102K USD -64.2%
Assets 29.3M USD -7.33%
Accounts Payable, Current 6.65M USD -0.78%
Liabilities, Current 20.9M USD +26%
Deferred Income Tax Liabilities, Net 971K USD +102%
Operating Lease, Liability, Noncurrent 2.23M USD +117%
Other Liabilities, Noncurrent 942K USD
Liabilities 24.1M USD +30.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax 185K USD
Retained Earnings (Accumulated Deficit) -152M USD -13.7%
Stockholders' Equity Attributable to Parent 4.25M USD -70.3%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 5.19M USD -60.5%
Liabilities and Equity 29.3M USD -7.33%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.34M USD +69%
Net Cash Provided by (Used in) Financing Activities 1.19M USD
Net Cash Provided by (Used in) Investing Activities -88K USD +13.7%
Common Stock, Shares, Issued 13.4M shares +62.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -194K USD +95.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4.24M USD -11.5%
Deferred Tax Assets, Valuation Allowance 36.2M USD +72.9%
Deferred Tax Assets, Gross 36.2M USD +52.1%
Operating Lease, Liability 3.07M USD +53.1%
Depreciation 200K USD 0%
Payments to Acquire Property, Plant, and Equipment 88K USD -13.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -17.9M USD -459%
Lessee, Operating Lease, Liability, to be Paid 3.74M USD +68.5%
Property, Plant and Equipment, Gross 905K USD -19.9%
Operating Lease, Liability, Current 832K USD -14.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 969K USD +120%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.05M USD +21.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure +38%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 675K USD +210%
Lessee, Operating Lease, Liability, to be Paid, Year Three 756K USD +103%
Lessee, Operating Lease, Liability, to be Paid, Year Four 470K USD +145%
Operating Lease, Payments 1.38M USD -14.5%
Additional Paid in Capital 156M USD +4.15%
Amortization of Intangible Assets 657K USD -33.3%
Depreciation, Depletion and Amortization 74K USD -92.1%
Deferred Tax Assets, Net of Valuation Allowance 0 USD -100%
Share-based Payment Arrangement, Expense 10K USD -98.5%